Cancer Targeted Therapy Market Report

Europe Cancer Targeted Therapy Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 04, 2020
  • PAGES：137
  • REPORT CODE：GMM536759
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Cancer Targeted Therapy market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Cancer Targeted Therapy Market Segmentations:

    By Player:

    • Advaxis

    • Merck

    • NeoStem Oncology

    • Peregrine Pharmaceuticals

    • Novartis

    • Teva

    • Seattle Genetics

    • ImmunoCellular Therapeutics

    • ImmunoGen

    • Northwest Biotherapeutics

    • NewLink Genetics

    • GalaxoSmithKline

    • Johnson & Johnson

    • Bind Therapeutics

    • Inovio Pharmaceuticals

    • Bristol Mayer Squibb

    • Genetech

    • Roche

    • Galena Biopharma

    • Boehringer Ingelheim

    • Dendreon Corporation

    • Pfizer

    • Celldex Therapeutics

    • Sanofi

    • Eli Lily

    By Type:

    • Tumor Antigens As Targets of Antibodies

    • Development of Antibodies for Clinical Purposes

    • Complement Dependent Cytotoxicity (CDC)

    • Signal Transduction Changes

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cancer Targeted Therapy Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Cancer Targeted Therapy Market Size and Growth Rate of Tumor Antigens As Targets of Antibodies from 2014 to 2026

    • 1.3.2 Europe Cancer Targeted Therapy Market Size and Growth Rate of Development of Antibodies for Clinical Purposes from 2014 to 2026

    • 1.3.3 Europe Cancer Targeted Therapy Market Size and Growth Rate of Complement Dependent Cytotoxicity (CDC) from 2014 to 2026

    • 1.3.4 Europe Cancer Targeted Therapy Market Size and Growth Rate of Signal Transduction Changes from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Cancer Targeted Therapy Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.2 Europe Cancer Targeted Therapy Market Size and Growth Rate of Clinic from 2014 to 2026

    • 1.4.3 Europe Cancer Targeted Therapy Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Cancer Targeted Therapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Cancer Targeted Therapy by Major Types

      • 3.4.1 Market Size and Growth Rate of Tumor Antigens As Targets of Antibodies

      • 3.4.2 Market Size and Growth Rate of Development of Antibodies for Clinical Purposes

      • 3.4.3 Market Size and Growth Rate of Complement Dependent Cytotoxicity (CDC)

      • 3.4.4 Market Size and Growth Rate of Signal Transduction Changes

    4 Segmentation of Cancer Targeted Therapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Cancer Targeted Therapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Hospital for Construction

      • 4.4.2 Market Size and Growth Rate of Clinic for Construction

      • 4.4.3 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Cancer Targeted Therapy Production Analysis by Top Regions

    • 5.2 Europe Cancer Targeted Therapy Consumption Analysis by Top Regions

    • 5.3 Europe Cancer Targeted Therapy Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

      • 5.3.3 France Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

    6 Product Circulation of Cancer Targeted Therapy Market among Top Countries

    • 6.1 Top 5 Export Countries in Cancer Targeted Therapy Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Cancer Targeted Therapy Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Cancer Targeted Therapy Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Cancer Targeted Therapy Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Cancer Targeted Therapy Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Cancer Targeted Therapy Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Cancer Targeted Therapy Landscape Analysis

    • 7.1 Germany Cancer Targeted Therapy Landscape Analysis by Major Types

    • 7.2 Germany Cancer Targeted Therapy Landscape Analysis by Major End-Users

    8. UK Cancer Targeted Therapy Landscape Analysis

    • 8.1 UK Cancer Targeted Therapy Landscape Analysis by Major Types

    • 8.2 UK Cancer Targeted Therapy Landscape Analysis by Major End-Users

    9. France Cancer Targeted Therapy Landscape Analysis

    • 9.1 France Cancer Targeted Therapy Landscape Analysis by Major Types

    • 9.2 France Cancer Targeted Therapy Landscape Analysis by Major End-Users

    10. Italy Cancer Targeted Therapy Landscape Analysis

    • 10.1 Italy Cancer Targeted Therapy Landscape Analysis by Major Types

    • 10.2 Italy Cancer Targeted Therapy Landscape Analysis by Major End-Users

    11. Spain Cancer Targeted Therapy Landscape Analysis

    • 11.1 Spain Cancer Targeted Therapy Landscape Analysis by Major Types

    • 11.2 Spain Cancer Targeted Therapy Landscape Analysis by Major End-Users

    12. Poland Cancer Targeted Therapy Landscape Analysis

    • 12.1 Poland Cancer Targeted Therapy Landscape Analysis by Major Types

    • 12.2 Poland Cancer Targeted Therapy Landscape Analysis by Major End-Users

    13. Russia Cancer Targeted Therapy Landscape Analysis

    • 13.1 Russia Cancer Targeted Therapy Landscape Analysis by Major Types

    • 13.2 Russia Cancer Targeted Therapy Landscape Analysis by Major End-Users

    14. Switzerland Cancer Targeted Therapy Landscape Analysis

    • 14.1 Switzerland Cancer Targeted Therapy Landscape Analysis by Major Types

    • 14.2 Switzerland Cancer Targeted Therapy Landscape Analysis by Major End-Users

    15. Turkey Cancer Targeted Therapy Landscape Analysis

    • 15.1 Turkey Cancer Targeted Therapy Landscape Analysis by Major Types

    • 15.2 Turkey Cancer Targeted Therapy Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Targeted Therapy Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Targeted Therapy Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Targeted Therapy Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Targeted Therapy Landscape Analysis by Top Countries

      • 16.3.1 Denmark Cancer Targeted Therapy Market Volume and Growth Rate

      • 16.3.2 Finland Cancer Targeted Therapy Market Volume and Growth Rate

      • 16.3.3 Norway Cancer Targeted Therapy Market Volume and Growth Rate

      • 16.3.4 Sweden Cancer Targeted Therapy Market Volume and Growth Rate

      • 16.3.6 Iceland Cancer Targeted Therapy Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Cancer Targeted Therapy Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Cancer Targeted Therapy Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Cancer Targeted Therapy Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Cancer Targeted Therapy Landscape Analysis by Top Countries

      • 17.3.1 Belgium Cancer Targeted Therapy Market Volume and Growth Rate

      • 17.3.2 Netherlands Cancer Targeted Therapy Market Volume and Growth Rate

      • 17.3.3 Luxembourg Cancer Targeted Therapy Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Cancer Targeted Therapy Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Cancer Targeted Therapy Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Cancer Targeted Therapy Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Cancer Targeted Therapy Landscape Analysis by Top Countries

      • 18.3.1 Estonia Cancer Targeted Therapy Market Volume and Growth Rate

      • 18.3.2 Latvia Cancer Targeted Therapy Market Volume and Growth Rate

      • 18.3.3 Lithuania Cancer Targeted Therapy Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Advaxis

      • 19.1.1 Advaxis Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Merck

      • 19.2.1 Merck Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 NeoStem Oncology

      • 19.3.1 NeoStem Oncology Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Peregrine Pharmaceuticals

      • 19.4.1 Peregrine Pharmaceuticals Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Novartis

      • 19.5.1 Novartis Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Teva

      • 19.6.1 Teva Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Seattle Genetics

      • 19.7.1 Seattle Genetics Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 ImmunoCellular Therapeutics

      • 19.8.1 ImmunoCellular Therapeutics Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 ImmunoGen

      • 19.9.1 ImmunoGen Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Northwest Biotherapeutics

      • 19.10.1 Northwest Biotherapeutics Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 NewLink Genetics

      • 19.11.1 NewLink Genetics Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 GalaxoSmithKline

      • 19.12.1 GalaxoSmithKline Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Johnson & Johnson

      • 19.13.1 Johnson & Johnson Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Bind Therapeutics

      • 19.14.1 Bind Therapeutics Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Inovio Pharmaceuticals

      • 19.15.1 Inovio Pharmaceuticals Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Bristol Mayer Squibb

      • 19.16.1 Bristol Mayer Squibb Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Genetech

      • 19.17.1 Genetech Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Roche

      • 19.18.1 Roche Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Galena Biopharma

      • 19.19.1 Galena Biopharma Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Boehringer Ingelheim

      • 19.20.1 Boehringer Ingelheim Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    • 19.21 Dendreon Corporation

      • 19.21.1 Dendreon Corporation Company Profile and Development Status

      • 19.21.2 Market Performance

      • 19.21.3 Product and Service Introduction

    • 19.22 Pfizer

      • 19.22.1 Pfizer Company Profile and Development Status

      • 19.22.2 Market Performance

      • 19.22.3 Product and Service Introduction

    • 19.23 Celldex Therapeutics

      • 19.23.1 Celldex Therapeutics Company Profile and Development Status

      • 19.23.2 Market Performance

      • 19.23.3 Product and Service Introduction

    • 19.24 Sanofi

      • 19.24.1 Sanofi Company Profile and Development Status

      • 19.24.2 Market Performance

      • 19.24.3 Product and Service Introduction

    • 19.25 Eli Lily

      • 19.25.1 Eli Lily Company Profile and Development Status

      • 19.25.2 Market Performance

      • 19.25.3 Product and Service Introduction

    The List of Tables and Figures (Totals 79 Figures and 202 Tables)

    • Figure Product Picture

    • Figure Cancer Targeted Therapy Market Size and Growth Rate of Tumor Antigens As Targets of Antibodies Market, 2015 - 2026 (USD Million)

    • Figure Cancer Targeted Therapy Market Size and Growth Rate of Development of Antibodies for Clinical Purposes Market, 2015 - 2026 (USD Million)

    • Figure Cancer Targeted Therapy Market Size and Growth Rate of Complement Dependent Cytotoxicity (CDC) Market, 2015 - 2026 (USD Million)

    • Figure Cancer Targeted Therapy Market Size and Growth Rate of Signal Transduction Changes Market, 2015 - 2026 (USD Million)

    • Figure Cancer Targeted Therapy Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Cancer Targeted Therapy Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Cancer Targeted Therapy Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure UK Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure France Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Cancer Targeted Therapy Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Cancer Targeted Therapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Cancer Targeted Therapy

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Cancer Targeted Therapy by Different Types from 2014 to 2026

    • Table Consumption Share of Cancer Targeted Therapy by Different Types from 2014 to 2026

    • Figure Cancer Targeted Therapy Market Size and Growth Rate of Tumor Antigens As Targets of Antibodies Market, 2015 - 2026 (USD Million)

    • Figure Cancer Targeted Therapy Market Size and Growth Rate of Development of Antibodies for Clinical Purposes Market, 2015 - 2026 (USD Million)

    • Figure Cancer Targeted Therapy Market Size and Growth Rate of Complement Dependent Cytotoxicity (CDC) Market, 2015 - 2026 (USD Million)

    • Figure Cancer Targeted Therapy Market Size and Growth Rate of Signal Transduction Changes Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Cancer Targeted Therapy by Different End-Users from 2014 to 2026

    • Table Consumption Share of Cancer Targeted Therapy by Different End-Users from 2014 to 2026

    • Figure Cancer Targeted Therapy Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Cancer Targeted Therapy Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Cancer Targeted Therapy Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe Cancer Targeted Therapy Production by Major Regions

    • Table Europe Cancer Targeted Therapy Production Share by Major Regions

    • Figure Europe Cancer Targeted Therapy Production Share by Major Countries and Regions in 2014

    • Table Europe Cancer Targeted Therapy Consumption by Major Regions

    • Table Europe Cancer Targeted Therapy Consumption Share by Major Regions

    • Table Germany Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

    • Table UK Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

    • Table France Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

    • Table Italy Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

    • Table Spain Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

    • Table Poland Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

    • Table Russia Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

    • Table Switzerland Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

    • Table Turkey Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cancer Targeted Therapy Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Cancer Targeted Therapy Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Cancer Targeted Therapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Cancer Targeted Therapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Cancer Targeted Therapy Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Cancer Targeted Therapy Consumption by Types from 2014 to 2026

    • Table Germany Cancer Targeted Therapy Consumption Share by Types from 2014 to 2026

    • Table Germany Cancer Targeted Therapy Consumption by End-Users from 2014 to 2026

    • Table Germany Cancer Targeted Therapy Consumption Share by End-Users from 2014 to 2026

    • Table UK Cancer Targeted Therapy Consumption by Types from 2014 to 2026

    • Table UK Cancer Targeted Therapy Consumption Share by Types from 2014 to 2026

    • Table UK Cancer Targeted Therapy Consumption by End-Users from 2014 to 2026

    • Table UK Cancer Targeted Therapy Consumption Share by End-Users from 2014 to 2026

    • Table France Cancer Targeted Therapy Consumption by Types from 2014 to 2026

    • Table France Cancer Targeted Therapy Consumption Share by Types from 2014 to 2026

    • Table France Cancer Targeted Therapy Consumption by End-Users from 2014 to 2026

    • Table France Cancer Targeted Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Italy Cancer Targeted Therapy Consumption by Types from 2014 to 2026

    • Table Italy Cancer Targeted Therapy Consumption Share by Types from 2014 to 2026

    • Table Italy Cancer Targeted Therapy Consumption by End-Users from 2014 to 2026

    • Table Italy Cancer Targeted Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Spain Cancer Targeted Therapy Consumption by Types from 2014 to 2026

    • Table Spain Cancer Targeted Therapy Consumption Share by Types from 2014 to 2026

    • Table Spain Cancer Targeted Therapy Consumption by End-Users from 2014 to 2026

    • Table Spain Cancer Targeted Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Poland Cancer Targeted Therapy Consumption by Types from 2014 to 2026

    • Table Poland Cancer Targeted Therapy Consumption Share by Types from 2014 to 2026

    • Table Poland Cancer Targeted Therapy Consumption by End-Users from 2014 to 2026

    • Table Poland Cancer Targeted Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Russia Cancer Targeted Therapy Consumption by Types from 2014 to 2026

    • Table Russia Cancer Targeted Therapy Consumption Share by Types from 2014 to 2026

    • Table Russia Cancer Targeted Therapy Consumption by End-Users from 2014 to 2026

    • Table Russia Cancer Targeted Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Cancer Targeted Therapy Consumption by Types from 2014 to 2026

    • Table Switzerland Cancer Targeted Therapy Consumption Share by Types from 2014 to 2026

    • Table Switzerland Cancer Targeted Therapy Consumption by End-Users from 2014 to 2026

    • Table Switzerland Cancer Targeted Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Cancer Targeted Therapy Consumption by Types from 2014 to 2026

    • Table Turkey Cancer Targeted Therapy Consumption Share by Types from 2014 to 2026

    • Table Turkey Cancer Targeted Therapy Consumption by End-Users from 2014 to 2026

    • Table Turkey Cancer Targeted Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Targeted Therapy Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Targeted Therapy Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Targeted Therapy Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Targeted Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Targeted Therapy Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Cancer Targeted Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Cancer Targeted Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Cancer Targeted Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Cancer Targeted Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Cancer Targeted Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Cancer Targeted Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cancer Targeted Therapy Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cancer Targeted Therapy Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cancer Targeted Therapy Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cancer Targeted Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cancer Targeted Therapy Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Cancer Targeted Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Cancer Targeted Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Cancer Targeted Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Cancer Targeted Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cancer Targeted Therapy Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cancer Targeted Therapy Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cancer Targeted Therapy Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cancer Targeted Therapy Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cancer Targeted Therapy Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Cancer Targeted Therapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Cancer Targeted Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Cancer Targeted Therapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Cancer Targeted Therapy Market Volume and Growth Rate from 2014 to 2026

    • Table Advaxis Profiles

    • Table Advaxis Production, Value, Price, Gross Margin 2014-2019

    • Table Advaxis Product benchmarking

    • Table Advaxis Strategic initiatives

    • Table Advaxis SWOT analysis

    • Table Merck Profiles

    • Table Merck Production, Value, Price, Gross Margin 2014-2019

    • Table Merck Product benchmarking

    • Table Merck Strategic initiatives

    • Table Merck SWOT analysis

    • Table NeoStem Oncology Profiles

    • Table NeoStem Oncology Production, Value, Price, Gross Margin 2014-2019

    • Table NeoStem Oncology Product benchmarking

    • Table NeoStem Oncology Strategic initiatives

    • Table NeoStem Oncology SWOT analysis

    • Table Peregrine Pharmaceuticals Profiles

    • Table Peregrine Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Peregrine Pharmaceuticals Product benchmarking

    • Table Peregrine Pharmaceuticals Strategic initiatives

    • Table Peregrine Pharmaceuticals SWOT analysis

    • Table Novartis Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Novartis Product benchmarking

    • Table Novartis Strategic initiatives

    • Table Novartis SWOT analysis

    • Table Teva Profiles

    • Table Teva Production, Value, Price, Gross Margin 2014-2019

    • Table Teva Product benchmarking

    • Table Teva Strategic initiatives

    • Table Teva SWOT analysis

    • Table Seattle Genetics Profiles

    • Table Seattle Genetics Production, Value, Price, Gross Margin 2014-2019

    • Table Seattle Genetics Product benchmarking

    • Table Seattle Genetics Strategic initiatives

    • Table Seattle Genetics SWOT analysis

    • Table ImmunoCellular Therapeutics Profiles

    • Table ImmunoCellular Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table ImmunoCellular Therapeutics Product benchmarking

    • Table ImmunoCellular Therapeutics Strategic initiatives

    • Table ImmunoCellular Therapeutics SWOT analysis

    • Table ImmunoGen Profiles

    • Table ImmunoGen Production, Value, Price, Gross Margin 2014-2019

    • Table ImmunoGen Product benchmarking

    • Table ImmunoGen Strategic initiatives

    • Table ImmunoGen SWOT analysis

    • Table Northwest Biotherapeutics Profiles

    • Table Northwest Biotherapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Northwest Biotherapeutics Product benchmarking

    • Table Northwest Biotherapeutics Strategic initiatives

    • Table Northwest Biotherapeutics SWOT analysis

    • Table NewLink Genetics Profiles

    • Table NewLink Genetics Production, Value, Price, Gross Margin 2014-2019

    • Table NewLink Genetics Product benchmarking

    • Table NewLink Genetics Strategic initiatives

    • Table NewLink Genetics SWOT analysis

    • Table GalaxoSmithKline Profiles

    • Table GalaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

    • Table GalaxoSmithKline Product benchmarking

    • Table GalaxoSmithKline Strategic initiatives

    • Table GalaxoSmithKline SWOT analysis

    • Table Johnson & Johnson Profiles

    • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Johnson & Johnson Product benchmarking

    • Table Johnson & Johnson Strategic initiatives

    • Table Johnson & Johnson SWOT analysis

    • Table Bind Therapeutics Profiles

    • Table Bind Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Bind Therapeutics Product benchmarking

    • Table Bind Therapeutics Strategic initiatives

    • Table Bind Therapeutics SWOT analysis

    • Table Inovio Pharmaceuticals Profiles

    • Table Inovio Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Inovio Pharmaceuticals Product benchmarking

    • Table Inovio Pharmaceuticals Strategic initiatives

    • Table Inovio Pharmaceuticals SWOT analysis

    • Table Bristol Mayer Squibb Profiles

    • Table Bristol Mayer Squibb Production, Value, Price, Gross Margin 2014-2019

    • Table Bristol Mayer Squibb Product benchmarking

    • Table Bristol Mayer Squibb Strategic initiatives

    • Table Bristol Mayer Squibb SWOT analysis

    • Table Genetech Profiles

    • Table Genetech Production, Value, Price, Gross Margin 2014-2019

    • Table Genetech Product benchmarking

    • Table Genetech Strategic initiatives

    • Table Genetech SWOT analysis

    • Table Roche Profiles

    • Table Roche Production, Value, Price, Gross Margin 2014-2019

    • Table Roche Product benchmarking

    • Table Roche Strategic initiatives

    • Table Roche SWOT analysis

    • Table Galena Biopharma Profiles

    • Table Galena Biopharma Production, Value, Price, Gross Margin 2014-2019

    • Table Galena Biopharma Product benchmarking

    • Table Galena Biopharma Strategic initiatives

    • Table Galena Biopharma SWOT analysis

    • Table Boehringer Ingelheim Profiles

    • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

    • Table Boehringer Ingelheim Product benchmarking

    • Table Boehringer Ingelheim Strategic initiatives

    • Table Boehringer Ingelheim SWOT analysis

    • Table Dendreon Corporation Profiles

    • Table Dendreon Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Dendreon Corporation Product benchmarking

    • Table Dendreon Corporation Strategic initiatives

    • Table Dendreon Corporation SWOT analysis

    • Table Pfizer Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Pfizer Product benchmarking

    • Table Pfizer Strategic initiatives

    • Table Pfizer SWOT analysis

    • Table Celldex Therapeutics Profiles

    • Table Celldex Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Celldex Therapeutics Product benchmarking

    • Table Celldex Therapeutics Strategic initiatives

    • Table Celldex Therapeutics SWOT analysis

    • Table Sanofi Profiles

    • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

    • Table Sanofi Product benchmarking

    • Table Sanofi Strategic initiatives

    • Table Sanofi SWOT analysis

    • Table Eli Lily Profiles

    • Table Eli Lily Production, Value, Price, Gross Margin 2014-2019

    • Table Eli Lily Product benchmarking

    • Table Eli Lily Strategic initiatives

    • Table Eli Lily SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US